CoreHip - Post Market Clinical Follow-Up Study

Prospective, Non-Interventional, Multicenter, Post-Market Clinical Follow-up Study CoreHip®

The study is designed as a prospective, non-interventional multicentre cohort study. The product under Investigation will be used in Routine clinical practice and according to the authorized Instructions for Use (IfU). Aim of this observational study is to collect clinical and radiological results of the CoreHip® endoprosthesis system in a Standard Patient Population and when used in Routine clinical practice.

The CoreHip® System has a range of different stem designs to address most of the indications and anatomical conditions met in Primary THA patients within one implant and Instrument System.

Inclusion Criteria:

• Patient age ≥ 18 years
• Indication for THA with a CoreHip® stem
• Written informed consent

Exclusion Criteria:

• Pregnancy
• Patient age < 18 years
• Patient not able to regularly participate at the follow-up examinations